Mifepristone followed by home administration of buccal misoprostol for medical abortion up to 70 days of amenorrhoea in a general practice in Curaççao

By Boersma Adriana A.   Meyboom-de Jong Betty   Kleiverda Gunilla  

The European Journal of Contraception and Reproductive Health Care, Vol. 16, Iss. 2, 2011-04 ,pp. : 61-66

Informa Healthcare

Access to resources Recommend Favorite

Mifepristone medical abortion in Albania: Results from a pilot clinical research study

By Group The Medical Abortion Research   Bracken Hillary   Gliozheni Orion   Kati Kreston   Manoku Nikita   Moisiu Rubena   Shannon Caitlin   Tare Vjollca   Tasha Ilir   Winikoff Beverly  

The European Journal of Contraception and Reproductive Health Care, Vol. 11, Iss. 1, 2006-03 ,pp. : 38-46

Informa Healthcare

Access to resources Recommend Favorite

A two-stage increase in the dose of misoprostol improves the efficacy of medical abortion with mifepristone and prostaglandins

By Aubeny E.  

The European Journal of Contraception and Reproductive Health Care, Vol. 6, Iss. 1, 2001-03 ,pp. : 54-57

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and acceptability of early mifepristone-misoprostol medical abortion in Ukraine: Results of two clinical trials

By Raghavan Sheila  

The European Journal of Contraception and Reproductive Health Care, Vol. 18, Iss. 2, 2013-04 ,pp. : 112-119

Informa Healthcare

Access to resources Recommend Favorite

Acceptability and feasibility of the use of 400 μg of sublingual misoprostol after mifepristone for medical abortion up to 63 days since the last menstrual period: Evidence from Uzbekistan

By Raghavan Sheila  

The European Journal of Contraception and Reproductive Health Care, Vol. 18, Iss. 2, 2013-04 ,pp. : 104-111

Informa Healthcare

Access to resources Recommend Favorite